Combination Chemotherapy and Pegfilgrastim in Treating Men With Metastatic Germ Cell Tumors
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as bleomycin, etoposide, and cisplatin, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing. Colony-stimulating factors, such as pegfilgrastim, may increase the
number of immune cells found in bone marrow or peripheral blood and may help the immune
system recover from the side effects of chemotherapy. Giving combination chemotherapy
together with pegfilgrastim may kill more tumor cells.
PURPOSE: This phase II trial is studying the side effects and how well giving combination
chemotherapy together with pegfilgrastim works in treating men with metastatic germ cell
tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust